Cardiac Transthyretin Amyloidosis: Hidden in Plain Sight
Amyloidosis is an underappreciated medical condition with symptoms camouflaging as common medical comorbidities leading to its underdiagnosis due to its systemic involvement. Despite common misconceptions, amyloidosis and its systemic comorbidities are more prevalent and treatable than previously ac...
Saved in:
Main Authors: | Constantine N. Logothetis, Joel Fernandez, Damian A. Laber |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2021/2551964 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Specific therapeutic options for transthyretin amyloidosis
by: Zoltán Pozsonyi
Published: (2024-12-01) -
Accuracy of Established Prognostic Staging Systems for Cardiac Transthyretin Amyloidosis in the Tafamidis Era
by: Maximilian Leo Müller, MD, et al.
Published: (2025-02-01) -
Serum Biomarkers in Transthyretin Amyloidosis: An Overview of Neurofilaments, Cardiac, Renal, and Gastrointestinal Involvement
by: Valeria Guglielmino, et al.
Published: (2025-01-01) -
Hidden in Plain Sight: The 'Questions sur l’Encyclopédie' in the Nineteenth Century
by: Robert Morrissey, et al.
Published: (2024-11-01) -
Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis
by: Maria Papathanasiou, et al.
Published: (2022-06-01)